Oxford’s corona ticker trial postponed

Trials of the coronovirus invented by researchers at the University of Oxford, UK have been temporarily suspended. Authorities decided to postpone the trial after a volunteer in the United Kingdom fell in the third and final round. The UK-based BBC gave this information in a report on Wednesday.

According to the BBC, the event was temporarily suspended after a volunteer fell ill during the trial, but the person’s identity was not revealed. No details about the nature of his illness were available. However, he is kept under surveillance. Officials say vaccine trials will be closed worldwide until details of the man’s disease are found. However, it is hoped that the person will recover quickly.

This Oxford vaccine candidate did very well in the first and second stage tests. But there is danger in the third and last phase. At this stage, about 30,000 people are being vaccinated in various countries. The vaccine will be released in the market based on its success.

This Oxford vaccine is considered the most advanced vaccine for coronavirus worldwide. Meanwhile, four European countries have entered into an initial agreement with the company to pre-order 400 million doses of Corona ticker.

AstraZeneca, a British pharmaceutical company that is the marketing partner of Oxford Ticker, hopes to launch a trial soon. The organization says such cases are not new to large-scale clinical trials. This is a kind of routine work.

A spokesperson at Oxford University gave a similar view. He said that such incidents can happen on a large scale. Some people may just get sick. In that case they are kept under surveillance. Researchers are trying to find out if vaccines have any role in getting sick.

In December 2019, coronovirus spread from Wuhan, capital of Hubei province of China. Although more than 63,000 people have been infected in the country of origin, China, the spread of the virus has decreased. However, the prevalence of this virus is increasing in other countries of the world. The World Health Organization (WHO) declared a global epidemic on March 11 in view of a 13-fold increase in the incidence of coronavirus outside China. Scientists are working hard to develop a vaccine against the virus.

Add a Comment

Your email address will not be published. Required fields are marked *